Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Rousselle

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Pharmaceutical Research|November 19, 2003
In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrierSalvatore Cisternino, Christophe Rousselle, Marcel Debray, et al.
Journal of Drug Targeting|August 8, 2002
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategyChristophe Rousselle, Philippe Clair, Jamal Temsamani, et al.
Regulatory Toxicology and Pharmacology : RTP|January 30, 2026
Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new Biomarkers into OECD Test GuidelinesClaire Beausoleil, Christophe Rousselle, Eren Ozcagli, et al.
Regulatory Toxicology and Pharmacology : RTP|May 20, 2026
Erratum to "Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new Biomarkers into OECD test Guidelines" [Regul. Toxicol. Pharm.(167) 106041]Claire Beausoleil, Christophe Rousselle, Eren Ozcagli, et al.
Toxicology Letters|January 13, 2021
Refinement of health-based guidance values for cadmium in the French population based on modellingStéphane Leconte, Christophe Rousselle, Laurent Bodin, et al.
Molecular and Cellular Endocrinology|February 27, 2018
Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruptionBrigitte Le Magueresse-Battistoni, Luc Multigner, Claire Beausoleil, et al.
Toxicology Letters|May 14, 2011
Haber's rule duration adjustments should not be used systematically for risk assessment in public health decision-makingEmel Belkebir, Christophe Rousselle, Cédric Duboudin, et al.
International Journal of Occupational Medicine and Environmental Health|March 17, 2018
Experiencing a probabilistic approach to clarify and disclose uncertainties when setting occupational exposure limitsDavid Vernez, Sandrine Fraize-Frontier, Raymond Vincent, et al.
Pharmaceutical Research|June 24, 2003
Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cellsSalvatore Cisternino, Christophe Rousselle, Aurelio Lorico, et al.
AAPS Pharmsci|March 21, 2003
Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectorsGuillaume Drin, Christophe Rousselle, Jean-Michel Scherrmann, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Pharmaceutical Research|November 19, 2003
In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrierSalvatore Cisternino, Christophe Rousselle, Marcel Debray, et al.
Journal of Drug Targeting|August 8, 2002
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategyChristophe Rousselle, Philippe Clair, Jamal Temsamani, et al.
Regulatory Toxicology and Pharmacology : RTP|January 30, 2026
Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new Biomarkers into OECD Test GuidelinesClaire Beausoleil, Christophe Rousselle, Eren Ozcagli, et al.
Regulatory Toxicology and Pharmacology : RTP|May 20, 2026
Erratum to "Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new Biomarkers into OECD test Guidelines" [Regul. Toxicol. Pharm.(167) 106041]Claire Beausoleil, Christophe Rousselle, Eren Ozcagli, et al.
Toxicology Letters|January 13, 2021
Refinement of health-based guidance values for cadmium in the French population based on modellingStéphane Leconte, Christophe Rousselle, Laurent Bodin, et al.
Molecular and Cellular Endocrinology|February 27, 2018
Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruptionBrigitte Le Magueresse-Battistoni, Luc Multigner, Claire Beausoleil, et al.
Toxicology Letters|May 14, 2011
Haber's rule duration adjustments should not be used systematically for risk assessment in public health decision-makingEmel Belkebir, Christophe Rousselle, Cédric Duboudin, et al.
International Journal of Occupational Medicine and Environmental Health|March 17, 2018
Experiencing a probabilistic approach to clarify and disclose uncertainties when setting occupational exposure limitsDavid Vernez, Sandrine Fraize-Frontier, Raymond Vincent, et al.
Pharmaceutical Research|June 24, 2003
Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cellsSalvatore Cisternino, Christophe Rousselle, Aurelio Lorico, et al.
AAPS Pharmsci|March 21, 2003
Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectorsGuillaume Drin, Christophe Rousselle, Jean-Michel Scherrmann, et al.
Pageof 7